Analyst Ratings January 22, 2026

UBS Elevates Charles Schwab Price Target Following Robust Financial Guidance

Financial Service Firm's Growth Prospects Prompt Analyst Upgrades Across the Board

By Sofia Navarro SCHW
UBS Elevates Charles Schwab Price Target Following Robust Financial Guidance
SCHW

UBS raised its price target for Charles Schwab to $125, maintaining a Buy rating, in the wake of the company's Q4 performance and confident 2026 outlook. The upward revision reflects solid earnings, revenue growth, and strong core business metrics, with other analysts similarly optimistic on Schwab's future prospects amid stable shareholder returns.

Key Points

  • UBS raises Charles Schwab's price target to $125 based on strong Q4 results and positive 2026 guidance.
  • Charles Schwab's revenue increased by 21.67% in the past 12 months, reflecting robust business growth.
  • Multiple analysts have lifted price targets, indicating broad market confidence in Schwab's future earnings potential.

UBS has increased its price target on Charles Schwab Corporation (NYSE:SCHW) to $125 from a previous target of $123, holding firm on its Buy recommendation as of Thursday. This updated target fits within a broader analyst consensus, with the current stock price at $104.96 and price targets from various analysts fluctuating between $94 and $148.

The revision follows Schwab's fourth-quarter financial reporting, which delivered earnings per share that met expectations, despite revenues slightly missing anticipations. Notwithstanding this minor shortfall, the company showcased impressive revenue growth of 21.67% over the trailing twelve months.

According to UBS, the decision to raise future earnings forecasts for 2026 through 2028 by roughly 2% was influenced by robust indicators in cash flow generation, capital returns, and core net new assets. Additionally, the firm highlighted the company’s steady guidance for 2026 and noted Schwab's remarkable streak of 37 years in consistent dividend payments, reinforcing its dedication to delivering shareholder value.

UBS further commented that management’s guidance tends to be cautious, suggesting possible upside in several areas including revenue growth, expense control, operating margins, balance sheet strength, and capital return policies.

The investment bank projects a compound annual growth rate of 17% in earnings per share through 2028 for Charles Schwab, coupled with the potential for additional gains derived from initiatives not currently accounted for in consensus forecasts.

Other financial institutions have also revised their outlooks on Schwab following the recent quarterly disclosure. Jefferies elevated its price target to $122, noting outperforming Q4 metrics such as increased average daily trades, peak client assets, and elevated margin balances. Raymond James raised its target to $121, emphasizing a favorable growth outlook despite quarterly results somewhat trailing expectations. Truist Securities aligned with this sentiment by pushing its target to $122 on the back of enhanced projections for net interest income, albeit with caution about higher anticipated costs. TD Cowen took a more optimistic stance, boosting its price target to $138 citing strong Q4 performance and an encouraging forecast for 2026-2027, underpinned by adjusted earnings per share estimates. Citizens maintained its Market Outperform rating and $120 price target, focusing on Schwab's continued growth momentum as it heads into 2026. Overall, these updates indicate a widely positive analyst sentiment toward Charles Schwab’s near-term and mid-term outlook.

In the realm of financial services and capital markets, Schwab’s performance and strategic guidance affect investor confidence and asset allocation decisions. The sustained dividend payments also echo stability valued by long-term shareholders.

While the company’s earnings aligned with forecasts, the slightly softer revenue figures suggest an area closely watched by market participants, with expenses and margin trends being other focal points for future performance assessments.

This article was prepared leveraging AI assistance and has undergone editorial review to ensure accuracy and quality.

Risks

  • Revenue performance slightly lagged expectations in Q4, signaling possible pressure points in top-line growth.
  • Higher anticipated expenses noted by some analysts could impact operating margins.
  • Management’s conservative guidance may mask underlying uncertainties in various financial metrics, including capital return and balance sheet management.

More from Analyst Ratings

KeyBanc Keeps Cautious View on LyondellBasell After Difficult Quarter, Cites Cash-Flow Limits vs. Dividend Feb 2, 2026 KeyBanc Sticks with Overweight on Murphy USA, Sees Near-Term Upside as Fuel Margins Improve Feb 2, 2026 KeyBanc Stands by Overweight Call on AppFolio, Flags ARPU and Product Drivers for 2026 Feb 2, 2026 KeyBanc Sticks With Overweight on Eastman; $74 Target Reflects Modest Upside Feb 2, 2026 Bernstein Boosts SanDisk Price Target to $1,000 After Robust Q2; Peers Follow Suit Feb 2, 2026